UNSPSC 51281668: Spectinomycin hydrochloride

This classification denotes an aminoglycoside antibiotic with the molecular formula C14H24N2O7.2ClH.5H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier HWT06H303Z, chemically known as 4h-pyrano(2,3-b)(1,4)benzodioxin-4-one, decahydro-4a,7,9-trihydroxy-2-methyl-6,8-bis(methylamino)-, dihydrochloride, pentahydrate but more generally known as spectinomycin dihydrochloride pentahydrate, which bears US NIH Compound Identifier 30971.

UNSPSC 51281668 Spectinomycin hydrochloride is a Commodity code nominally identifying a specific antibiotic pharmaceutical product, but recent state and local opportunities tagged under this code show little alignment with that scope. The recent solicitations span naloxone procurement, therapeutic pharmacy initiative direct-to-manufacturer programs, general medical and first aid supplies for emergency response, and multi-source generic pharmaceuticals and OTC products distributed through authorized wholesalers. None of these opportunities explicitly request spectinomycin hydrochloride or narrow-spectrum antibiotic procurement. The code appears to capture a broad range of pharmaceutical and medical supply acquisitions across state health agencies, county health departments, municipalities, and cooperative purchasing alliances rather than procurement of this specific drug substance. Issuing bodies include the Texas Health and Human Services Commission, Seminole County Florida, the City of Tampa, and the Minnesota Department of Administration (administering the MMCAP cooperative purchasing alliance).

Activity is distributed across Florida, Texas, and Minnesota, with MMCAP's multi-state cooperative vehicle serving Oregon and other participating jurisdictions. Representative recent opportunities include Seminole County's IFB 60459723LAS (due July 26, 2023) for 1,900 units of naloxone and 800 safe drug deactivation systems annually; the City of Tampa's IFB 26P00145 (due March 13, 2026) for 169 line items of medical and first aid supplies to the Tampa Fire Department Rescue Division with an estimated contract value of $700,000; the Texas HHS Commission's RFI HHS0017013 (due April 3, 2026) exploring direct-to-manufacturer prescription programs; and MMCAP's RFP S1070000015802 (due March 26, 2026) to establish multiple contracts for generic pharmaceuticals and OTC products distributed through AmerisourceBergen Drug Corporation, Cardinal Health, and Morris & Dickson. The code shows activity volume but lacks clear recent demand for spectinomycin hydrochloride specifically; vendors targeting this pharmaceutical should verify code alignment before pursuing opportunities tagged here.